(Q54472913)

30 May 2018

title

TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. (English)

1 reference

30 May 2018

14

Kohjiro Ueki

1 reference

30 May 2018

15

Takashi Kadowaki

1 reference

30 May 2018

author name string

Iseki Takamoto

1

1 reference

30 May 2018

Naoto Kubota

2

1 reference

30 May 2018

Keizo Nakaya

3

1 reference

30 May 2018

Katsuyoshi Kumagai

4

1 reference

30 May 2018

Shinji Hashimoto

5

1 reference

30 May 2018

Tetsuya Kubota

6

1 reference

30 May 2018

Mariko Inoue

7

1 reference

30 May 2018

Eiji Kajiwara

8

1 reference

30 May 2018

Hisayuki Katsuyama

9

1 reference

30 May 2018

Atsushi Obata

10

1 reference

30 May 2018

Yoshitaka Sakurai

11

1 reference

30 May 2018

Masahiko Iwamoto

12

1 reference

30 May 2018

Tadahiro Kitamura

13

1 reference

30 May 2018

publication date

8 December 2013

1 reference

30 May 2018

published in

Diabetologia

1 reference

30 May 2018

volume

57

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

542-553

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s00125-013-3131-6

exact match

0 references

cites work

Risk factors for worsening to diabetes in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Insights into insulin resistance and type 2 diabetes from knockout mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Wnt signaling in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Diversity of LEF/TCF action in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Wnt signalling: variety at the core.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Wnt signaling: relevance to beta-cell biology and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

The what, where, when and how of Wnt/β-catenin signaling in pancreas development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

The WNT signalling pathway and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Dominant-negative isoforms of Tcf/Lef proteins in development and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

A novel mechanism for the transcriptional regulation of Wnt signaling in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Role of MafA in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

MafA and MafB activity in pancreatic β cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Unique splicing pattern of the TCF7L2 gene in human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

TCF7L2 splice variants have distinct effects on beta-cell turnover and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Tcf3: a transcriptional regulator of axis induction in the early embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

A map of open chromatin in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3131-6

Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes

21 January 2018

1 reference

12 December 2020

Animal models of GWAS-identified type 2 diabetes genes

1 reference

12 December 2020

Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects

1 reference

12 December 2020

Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass

1 reference

12 December 2020

Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals

1 reference

12 December 2020

10.1007/S00125-013-3131-6

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

24317852

1 reference

30 May 2018